Literature DB >> 8020059

Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat.

F Gaytan1, A J Martinez-Fuentes, F Garcia-Navarro, H Vaudry, E Aguilar.   

Abstract

Pituitary adenylate cyclase activating peptide (PACAP) is a novel peptide isolated from the ovine hypothalamus. PACAP exists in 2 molecular forms with 27 (PACAP27) or 38 (PACAP38) amino acid residues. PACAP localization was studied by immunohistochemical methods in central (bone marrow and thymus) and peripheral (spleen, lymph nodes and duodenal mucosa) lymphoid tissues with antisera raised against PACAP27 or PACAP38. PACAP-positive cells were found in all lymphoid tissues examined. These cells were highly positive for PACAP38 but were negative for PACAP27. Morphologically, they were small mononuclear cells with relatively scarce cytoplasm and lymphocyte-like features. PACAP38-positive cells were abundant in peripheral lymphoid tissues (i.e., mesenteric lymph nodes). In the duodenal mucosa, PACAP38-positive cells were located either in the lamina propria or epithelium. These results suggest that PACAP38-positive cells are present within lymphoid tissues and may represent a lymphocyte-like cell subpopulation that has a potential role in cell-to-cell interactions in the immune system and in the integrated communication between neuroendocrine and immune systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020059     DOI: 10.1007/bf00306107

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  17 in total

1.  Identification of prolactin-like proteins synthesized by normal murine lymphocytes.

Authors:  D W Montgomery; J A LeFevre; E D Ulrich; C R Adamson; C F Zukoski
Journal:  Endocrinology       Date:  1990-11       Impact factor: 4.736

2.  Novel processing pathway for proopiomelanocortin in lymphocytes: endotoxin induction of a new prohormone-cleaving enzyme.

Authors:  D V Harbour; E M Smith; J E Blalock
Journal:  J Neurosci Res       Date:  1987       Impact factor: 4.164

3.  Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.

Authors:  I Tatsuno; P E Gottschall; A Arimura
Journal:  Endocrinology       Date:  1991-02       Impact factor: 4.736

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.

Authors:  C A Ottaway; G R Greenberg
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

Authors:  A Miyata; L Jiang; R D Dahl; C Kitada; K Kubo; M Fujino; N Minamino; A Arimura
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

7.  Intramucosal lymphocytes of the gut: Lyt-2 and thy-1 phenotype of the granulated cells and evidence for the presence of both T cells and mast cell precursors.

Authors:  J W Schrader; R Scollay; F Battye
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

8.  Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut.

Authors:  F Sundler; E Ekblad; A Absood; R Håkanson; K Köves; A Arimura
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

9.  Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes.

Authors:  A Arimura; A Somogyvári-Vigh; A Miyata; K Mizuno; D H Coy; C Kitada
Journal:  Endocrinology       Date:  1991-11       Impact factor: 4.736

Review 10.  Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research.

Authors:  A Arimura
Journal:  Regul Pept       Date:  1992-02-18
View more
  7 in total

1.  Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PAC1 in the periodontal ligament after tooth luxation.

Authors:  Sayako Nonaka; Hideki Kitaura; Keisuke Kimura; Masahiko Ishida; Teruko Takano-Yamamoto
Journal:  Cell Mol Neurobiol       Date:  2013-06-26       Impact factor: 5.046

2.  Expression of pituitary adenylate cyclase-activating polypeptide in the primary lymphoid organs of the duck Anas platyrhynchos.

Authors:  Caterina Squillacioti; Nicola Mirabella; Adriana De Luca; Giuseppe Paino
Journal:  J Anat       Date:  2006-07       Impact factor: 2.610

Review 3.  VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Authors:  J A Waschek
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 4.  Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.

Authors:  Yossan-Var Tan; James A Waschek
Journal:  ASN Neuro       Date:  2011-10-06       Impact factor: 4.146

5.  Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.

Authors:  Yossan-Var Tan; Catalina Abad; Yuqi Wang; Robert Lopez; James A Waschek
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 6.  Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

Review 7.  Effects of Pacap on Schwann Cells: Focus on Nerve Injury.

Authors:  Grazia Maugeri; Agata Grazia D'Amico; Giuseppe Musumeci; Dora Reglodi; Velia D'Agata
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.